Download presentation
Presentation is loading. Please wait.
Published byJanice Evans Modified over 6 years ago
1
Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis William L. Baker, PharmD, FCCP, Lindsay R. Smyth, PharmD, Daniel M. Riche, PharmD, Emily M. Bourret, PharmD, Kevin W. Chamberlin, PharmD, William B. White, MD, FASH, FAHA, FACP Journal of the American Society of Hypertension Volume 8, Issue 4, Pages e9 (April 2014) DOI: /j.jash Copyright © 2014 American Society of Hypertension Terms and Conditions
2
Figure 1 Prisma diagram. Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
3
Figure 2 Impact of SGLT2 inhibitors on systolic blood pressure.
Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
4
Figure 3 Impact of SGLT2 inhibitors on diastolic blood pressure.
Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
5
Figure 4 Random-effects meta-regression evaluating relationship between canagliflozin dose & mean change in SBP from baseline. Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
6
Figure 5 Funnel plot of orthostatic hypotension. The dark circles represent individual studies and the red open circles represent imputed filled studies. The black line represents the base-case treatment effect and the red line is the re-estimate adding the filled studies. Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
7
Supplemental Figure 1 Impact of SGLT2 inhibitors on systolic blood pressure by control. Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
8
Supplemental Figure 2 Impact of SGLT2 inhibitors on systolic blood pressure by drug. Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
9
Supplemental Figure 3 Impact of SGLT2 inhibitors on diastolic blood pressure by control. Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
10
Supplemental Figure 4 Impact of SGLT2 inhibitors on diastolic blood pressure by drug. Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
11
Supplemental Figure 5 Impact of SGLT2 inhibitors on orthostatic hypotension by drug. Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
12
Supplemental Figure 6 Impact of SGLT2 inhibitors on body weight by control. Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
13
Supplemental Figure 7 Impact of SGLT2 inhibitors on body weight by drug. Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
14
Supplemental Figure 8 Impact of SGLT2 inhibitors on hematocrit by control. Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
15
Supplemental Figure 9 Impact of SGLT2 inhibitors on hematocrit by drug. Journal of the American Society of Hypertension 2014 8, e9DOI: ( /j.jash ) Copyright © 2014 American Society of Hypertension Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.